These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30945381)

  • 41. Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database.
    Cho HW; Ouh YT; Lee JK; Hong JH
    J Gynecol Oncol; 2019 Jul; 30(4):e51. PubMed ID: 31074237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tamoxifen and risk of large bowel cancer in women with breast cancer.
    Newcomb PA; Solomon C; White E
    Breast Cancer Res Treat; 1999 Feb; 53(3):271-7. PubMed ID: 10369073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Local recurrence based on size after conservative surgery in breast cancer stage T1-T2. A population-based study].
    Martínez-Ramos D; Fortea-Sanchis C; Escrig-Sos J; Prats-de Puig M; Queralt-Martín R; Salvador-Sanchis JL
    Cir Cir; 2014; 82(3):252-61. PubMed ID: 25238466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
    Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
    PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonaspirin NSAIDs and contralateral breast cancer risk.
    Bens A; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Friis S; Mellemkjaer L
    Int J Cancer; 2019 Mar; 144(6):1243-1250. PubMed ID: 30362513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries.
    Hernandez I; He M; Brooks MM; Zhang Y
    JAMA Netw Open; 2018 Jun; 1(2):e180919. PubMed ID: 30646080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer.
    Ahn HY; Min HS; Yeo Y; Ma SH; Hwang Y; An JH; Choi HS; Keam B; Im SA; Park DJ; Park IA; Noh DY; Youn YK; Chung JK; Cho BY; Park SK; Park YJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3486-93. PubMed ID: 26147607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.
    Nechuta S; Chen WY; Cai H; Poole EM; Kwan ML; Flatt SW; Patterson RE; Pierce JP; Caan BJ; Ou Shu X
    Int J Cancer; 2016 May; 138(9):2088-97. PubMed ID: 26606746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The comparative safety of analgesics in older adults with arthritis.
    Solomon DH; Rassen JA; Glynn RJ; Lee J; Levin R; Schneeweiss S
    Arch Intern Med; 2010 Dec; 170(22):1968-76. PubMed ID: 21149752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
    Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
    Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
    Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
    JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of time to death after distant recurrence in breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence with opioid treatment in Germany in patients suffering from chronic non-malignant or cancer pain.
    Kostev K; Wartenberg F; Richter H; Reinwald M; Heilmaier C
    Curr Med Res Opin; 2015 Jun; 31(6):1157-63. PubMed ID: 25806648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.
    Wirtz HS; Calip GS; Buist DSM; Gralow JR; Barlow WE; Gray S; Boudreau DM
    Am J Epidemiol; 2017 Apr; 185(8):661-672. PubMed ID: 28338879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies.
    Shah A; Hayes CJ; Martin BC
    J Pain; 2017 Nov; 18(11):1374-1383. PubMed ID: 28711636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.
    Scherrer JF; Salas J; Bucholz KK; Schneider FD; Burroughs T; Copeland LA; Sullivan MD; Lustman PJ
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):560-8. PubMed ID: 27004714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active smoking and breast cancer risk: original cohort data and meta-analysis.
    Gaudet MM; Gapstur SM; Sun J; Diver WR; Hannan LM; Thun MJ
    J Natl Cancer Inst; 2013 Apr; 105(8):515-25. PubMed ID: 23449445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.